Cell apoptosis, autophagy and necroptosis in osteosarcoma treatment

被引：92

作者：

Li, Jing ^{[1
,2
]}

Yang, Zuozhang ^{[1
]}

Li, Yi ^{[3
]}

Xia, Junfeng ^{[1
]}

Li, Dongqi ^{[1
]}

Li, Huiling ^{[1
]}

Ren, Mingyan ^{[1
]}

Liao, Yedan ^{[1
]}

Yu, Shunling ^{[1
]}

Chen, Yanjin ^{[1
]}

Yang, Yihao ^{[1
]}

Zhang, Ya ^{[1
]}

机构：

[1] Kunming Med Univ, Tumor Hosp Yunnan Prov, Bone & Soft Tissue Tumors Res Ctr Yunnan Prov, Dept Orthopaed,Affiliated Hosp 3, Kunming, Yunnan, Peoples R China

[2] Peking Univ, Coll Life Sci, State Key Lab Prot & Plant Gene Res, Beijing, Peoples R China

[3] Kunming Gen Hosp Chengdu Mil Command, Dept Oncol, Kunming, Yunnan, Peoples R China

来源：

ONCOTARGET | 2016年 / 7卷 / 28期

基金：

中国博士后科学基金; 中国国家自然科学基金;

关键词：

apoptosis; autophagy; necroptosis; chemotherapy resistance; osteosarcoma; CELASTROL INDUCES APOPTOSIS; PROTEIN-KINASE; LUNG METASTASIS; IN-VITRO; PROTEASOME INHIBITOR; MEDIATED AUTOPHAGY; SIGNALING PATHWAY; DRUG-RESISTANCE; DOWN-REGULATION; DEATH RECEPTOR;

D O I：

10.18632/oncotarget.8206

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Osteosarcoma is the most common primary bone tumor in children and adolescents. Although combined therapy including surgery and multi-agent chemotherapy have resulted in great improvements in the overall survival of patients, chemoresistance remains an obstacle for the treatment of osteosarcoma. Molecular targets or effective agents that are actively involved in cell death including apoptosis, autophagy and necroptosis have been studied. We summarized how these agents (novel compounds, miRNAs, or proteins) regulate apoptotic, autophagic and necroptotic pathways; and discussed the current knowledge on the role of these new agents in chemotherapy resistance in osteosarcoma.

引用

页码：44763 / 44778

页数：16

共 50 条

[21] Autophagy prevents doxorubicin-induced apoptosis in osteosarcoma
Zhao, Dongxu
Yuan, Hongping
Yi, Fei
Meng, Chunyang
Zhu, Qingsan
MOLECULAR MEDICINE REPORTS, 2014, 9 (05) : 1975 - 1981
[22] The Expression Pattern of Non-apoptotic Cell Death Pathway in Osteosarcoma: Necroptosis and Autophagy as Backup Mechanisms for Therapeutics Strategy
Neykhonji, Marzieh
Nazem, Shima
Ghaedi, Hamid
Mirzaei, Alireza
Tavakoli-Yaraki, Masoumeh
Shahsavari, Zahra
INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2022, 15 (08)
[23] Machilin D Promotes Apoptosis and Autophagy, and Inhibits Necroptosis in Human Oral Squamous Cell Carcinoma Cells
Yun, Hyung-Mun
Kwon, Yoon-Ju
Kim, Eonmi
Chung, Hea-Jong
Park, Kyung-Ran
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
[24] CFLAR/c-FLIPL A star in the autophagy, apoptosis and necroptosis alliance
He, Ming-Xiao
He, You-Wen
AUTOPHAGY, 2013, 9 (05) : 791 - 793
[25] Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis
Zhao, Jianan
Jiang, Ping
Guo, Shicheng
Schrodi, Steven J.
He, Dongyi
FRONTIERS IN IMMUNOLOGY, 2021, 12
[26] Molecular Cell Biology of Apoptosis and Necroptosis in Cancer
Dillon, Christopher P.
Green, Douglas R.
APOPTOSIS IN CANCER PATHOGENESIS AND ANTI-CANCER THERAPY: NEW PERSPECTIVES AND OPPORTUNITIES, 2016, 930 : 1 - 23
[27] Autophagy, selective autophagy, and necroptosis in COPD
Mizumura, Kenji
Maruoka, Shuichiro
Shimizu, Tetsuo
Gon, Yasuhiro
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3165 - 3172
[28] Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma
Zhou, Pingting
Li, Yanyan
Li, Bo
Zhang, Meichao
Xu, Ci
Liu, Furao
Bian, Lei
Liu, Yuanhua
Yao, Yuan
Li, Dong
CELL CYCLE, 2018, 17 (08) : 997 - 1006
[29] Dynamic regulation of Apoptosis, Autophagy, and Necroptosis in Ischemic Postconditioning Cardioprotection: The Importance of Adiponectin
Zhu, Qiqi
Li, Haobo
Xie, Xiang
Ge, Zhidong
Lian, Qingquan
Ge, Renshan
Xia, Zhengyuan
FASEB JOURNAL, 2017, 31
[30] The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells
Yan, S.
Yang, X.
Chen, T.
Xi, Z.
Jiang, X.
CANCER GENE THERAPY, 2014, 21 (05) : 188 - 193

← 1 2 3 4 5 →